These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31689349)

  • 41. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization.
    Pezhouh MK; Miller JA; Sharma R; Borzik D; Eze O; Waters K; Westerhoff MA; Parian AM; Lazarev MG; Voltaggio L
    Hum Pathol; 2018 Dec; 82():187-192. PubMed ID: 30120969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project.
    Davis RL; Kramarz P; Bohlke K; Benson P; Thompson RS; Mullooly J; Black S; Shinefield H; Lewis E; Ward J; Marcy SM; Eriksen E; Destefano F; Chen R;
    Arch Pediatr Adolesc Med; 2001 Mar; 155(3):354-9. PubMed ID: 11231801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus?
    Narula N; Yamamura DL; Marshall JK
    Can J Gastroenterol; 2010 Feb; 24(2):121-5. PubMed ID: 20151071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    Satyam VR; Li PH; Reich J; Qazi T; Noronha A; Wasan SK; Farraye FA
    Dig Dis Sci; 2020 Oct; 65(10):2986-2991. PubMed ID: 31897892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.
    Abitbol Y; Laharie D; Cosnes J; Allez M; Nancey S; Amiot A; Aubourg A; Fumery M; Altwegg R; Michetti P; Chanteloup E; Seksik P; Baudry C; Flamant M; Bouguen G; Stefanescu C; Bourrier A; Bommelaer G; Dib N; Bigard MA; Viennot S; Hébuterne X; Gornet JM; Marteau P; Bouhnik Y; Abitbol V; Nahon S;
    J Crohns Colitis; 2016 Oct; 10(10):1179-85. PubMed ID: 27402916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preventing infective complications in inflammatory bowel disease.
    Mill J; Lawrance IC
    World J Gastroenterol; 2014 Aug; 20(29):9691-8. PubMed ID: 25110408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimizing Immunization Strategies in Patients with IBD.
    Caldera F; Ley D; Hayney MS; Farraye FA
    Inflamm Bowel Dis; 2021 Jan; 27(1):123-133. PubMed ID: 32232388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Ramos GP; Stroh G; Al-Bawardy B; Faubion WA; Papadakis KA; Escalante P
    Inflamm Bowel Dis; 2018 Sep; 24(10):2272-2277. PubMed ID: 29718223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adherence to a predefined vaccination program in patients with inflammatory bowel disease.
    Ruiz-Cuesta P; González-Alayón C; Jurado-García J; Iglesias-Flores EM; Barranco-Quintana JL; García-García L; Salgueiro-Rodríguez IM; Benitez-Cantero JM; García-Sánchez V
    Gastroenterol Hepatol; 2016; 39(6):385-92. PubMed ID: 26601992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunisation status of children and adolescents with a new diagnosis of inflammatory bowel disease.
    Ford T; Danchin M; McMinn A; Perrett K; Alex G; Crawford NW
    BMC Infect Dis; 2022 Jan; 22(1):6. PubMed ID: 34983407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EBV Status and Thiopurine Use in Pediatric IBD.
    Gordon J; Ramaswami A; Beuttler M; Jossen J; Pittman N; Lai J; Dunkin D; Benkov K; Dubinsky M
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):711-4. PubMed ID: 26655944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 'cocoon immunization strategy' among patients with inflammatory bowel disease.
    Waszczuk K; Waszczuk E; Mulak A; Szenborn L; Paradowski L
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):249-53. PubMed ID: 25569568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary.
    Veereman-Wauters G; de Ridder L; Veres G; Kolacek S; Fell J; Malmborg P; Koletzko S; Dias JA; Misak Z; Rahier JF; Escher JC;
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):830-7. PubMed ID: 22584748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization Coverage in Children with Inflammatory Bowel Disease.
    Kowalska-Duplaga K; Baranowska-Nowak M; Nescioruk M; Banasiuk M; Karolewska-Bochenek K; Łazowska-Przeorek I; Radzikowski A; Banaszkiewicz A
    Adv Exp Med Biol; 2019; 1113():83-88. PubMed ID: 29429027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of antibody response to polysaccharide vaccine and switched memory B cells in pediatric patients with inflammatory bowel disease.
    Fallahi G; Aghamohammadi A; Khodadad A; Hashemi M; Mohammadinejad P; Asgarian-Omran H; Najafi M; Farhmand F; Motamed F; Soleimani K; Soheili H; Parvaneh N; Darabi B; Nasiri Kalmarzi R; Pourhamdi S; Abolhassani H; Mirminachi B; Rezaei N
    Gut Liver; 2014 Jan; 8(1):24-8. PubMed ID: 24516697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.
    Beaugerie L; Rahier JF; Kirchgesner J
    Clin Gastroenterol Hepatol; 2020 May; 18(6):1324-1335.e2. PubMed ID: 32059920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenecity of hepatitis A and B vaccination in pediatric patients with inflammatory bowel disease.
    Urganci N; Kalyoncu D
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):412-15. PubMed ID: 23841120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.
    Belle A; Baumann C; Bigard MA; Zallot C; Gizard E; Guéant JL; Bronowicki JP; Peyrin-Biroulet L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):877-81. PubMed ID: 26121376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.
    Kochar B; Cai W; Cagan A; Ananthakrishnan AN
    Gastroenterology; 2020 Jun; 158(8):2104-2111.e2. PubMed ID: 32105728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epstein-Barr Virus Status and Subsequent Thiopurine Exposure Within a Paediatric Inflammatory Bowel Disease Population.
    Harris RE; Hegde V; Curtis L; Garrick V; Gervais L; Armstrong L; Delahunty C; Eccleston A; Al-Hourani G; Flynn DM; Merrick V; Barclay AR; Tayler R; Hansen R; Russell RK
    J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):358-362. PubMed ID: 34091548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.